This inventor holds 1 USPTO granted patent. Top assignee: Teijin Pharma Limited. Active years: 2009.
Company Filing History:
Years Active: 2009
Title: Aiko Fujino: Innovator in Kinase Inhibition
Introduction
Aiko Fujino is a notable inventor based in Hino, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that exhibit kinase inhibiting activity. His work is crucial in addressing various medical conditions, including inflammatory diseases and cancer.
Latest Patents
Aiko Fujino holds a patent for Pyrazolo[1,5-A] pyrimidine derivatives. The compounds represented by this patent, along with their pharmaceutically acceptable salts, demonstrate excellent kinase inhibiting activity. These drugs are expected to be effective as therapeutic or prophylactic agents for disorders mediated by protein kinases, such as autoimmune diseases, destructive bone disorders, and tumor growth.
Career Highlights
Aiko Fujino is associated with Teijin Pharma Limited, where he continues to innovate in the pharmaceutical sector. His work has the potential to lead to significant advancements in treatment options for various diseases.
Collaborations
Aiko collaborates with talented coworkers, including Mika Takakuwa and Tomomi Kosugi. Their combined expertise contributes to the success of their projects and the advancement of medical science.
Conclusion
Aiko Fujino's contributions to the field of kinase inhibition highlight his role as an important inventor in the pharmaceutical industry. His innovative work promises to improve therapeutic options for patients suffering from serious medical conditions.